Cleared Traditional

K241331 - MuscleView

K241331 is an FDA 510(k) clearance for MuscleView, manufactured by Springbok, Inc.. The device is a Class 2 Radiology device with product code LNH cleared through the Traditional 510(k) pathway after a 144-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2024
Decision
144d
Days
Class 2
Risk

K241331 is an FDA 510(k) clearance for the MuscleView. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Springbok, Inc. (Charlottesville, US). The FDA issued a Cleared decision on October 1, 2024 after a review of 144 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Springbok, Inc. devices

FDA 510(k) Submission Details - K241331

510(k) Number K241331 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2024
Decision Date October 01, 2024
Days to Decision 144 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 107d · This submission: 144d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LNH Device Classification - Class 2, Special Controls

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 840
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K241331.
MROpen Evo (03-2000-00)
K242258 · Asg Superconductors S.P.A. · Nov 2024
SIGNA MAGNUS
K241242 · Ge Medical Systems, LLC · Oct 2024
VitruvianScan (v1.0)
K241925 · Perspectum, Ltd. · Oct 2024
MyoStrain (6.0)
K241607 · Myocardial Solutions, Inc. · Aug 2024
Vantage Galan 3T, MRT-3020, V10.0 with AiCE Reconstruction Processing Unit for MR
K241496 · Canon Medical Systems Corporation · Aug 2024
ECHELON Synergy MRI System
K241429 · Fujifilm Healthcare Corporation · Aug 2024